<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>diverse &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/diverse/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 17 Oct 2026 14:37:01 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>diverse &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Real-World Study Shows Sitagliptin Delivers Solid Blood Sugar Control in Diverse Type 2 Diabetes Patients</title>
		<link>https://bioengineer.org/real-world-study-shows-sitagliptin-delivers-solid-blood-sugar-control-in-diverse-type-2-diabetes-patients/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 17 Oct 2026 14:37:01 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Combination]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[diverse]]></category>
		<category><![CDATA[diversity]]></category>
		<category><![CDATA[Metformin]]></category>
		<category><![CDATA[outcomes]]></category>
		<category><![CDATA[populations]]></category>
		<category><![CDATA[real-world]]></category>
		<category><![CDATA[single-pill]]></category>
		<category><![CDATA[sitagliptin]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[type]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=428439</guid>

					<description><![CDATA[The DIVERSITY study arrives at a moment when clinicians increasingly recognize that the populations enrolled in randomized controlled trials rarely resemble the patients they see every day. Trial participants are typically younger, healthier, and more adherent than the average person]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">428439</post-id>	</item>
	</channel>
</rss>
